Clinical Trial Update: Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics of prototype modified-release formulations of apremilast in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2021-06-01